Clinicaltrials.gov is the world’s largest primary registry of clinical studies. For almost two decades now it has been helping physicians, patients, and regulators identify relevant trials and collect evidence.
There is an increasing number of varieties of drug agents in clinical use ranging from antibodies and proteins to nucleic acids and, increasingly, cellular and genetic therapies but the majority of drugs on the market and in development today are still small, synthetic molecules made in a chemistry laboratory.
A new view brings a new perspective… …its late February and I am sitting in our new Cambridge office looking at an unusually snowy scene of lawns and woodland.
As we all work busily in our own corners of drug discovery, be it in Pharma, biotech or academia, ask yourself the question – are you just pushing that horse a little more or are you genuinely imagining and creating the model T of the 21st century?
Recently we welcomed the news that we have officially selected a study name for BenevolentAI's first clinical trial.